Delivery Order SPE2DB20D2014-SPE2DB25FA72F

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,702.42, is for the delivery of CellCept 500 mg tablets to support military treatment facilities and federal healthcare programs. It is a firm fixed-price contract with an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,927.92 firm fixed-price delivery order is for the supply of 4,566,639,193 CellCept 500 mg tablets, a medication used in organ transplant recipients. The contract has an ultimate completion date of December 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,069.14 firm fixed-price delivery order is for the supply of 4,566,810,176 units of the drug CellCept 500 mg tablets. The contract has an ultimate completion date of December 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, valued at $9,377.75, is for the delivery of 4564312523 - CELLCEPT 500 MG TABLET 100S, a prescription medication. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of April...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB24FD7A5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $25,589.91 firm-fixed-price delivery order is for the supply of 4,565,732,478 units of CellCept 500 mg tablets. The contract has an ultimate completion date of September 10, 2024 and was awarded on September 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, with a ceiling value of $76,289.26, was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, with an ultimate completion date of August 30, 2021. This is a firm fixed-price delivery order contract, and it was not designated as a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $2,325.88, is for the delivery of CellCept 500 mg tablets in quantities of 100. This is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. The contract has no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several significant Indefinite...
This federal contract award is for the delivery of CellCept 500 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $16,742.95 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a wide range of medical products and supplies. The contract, valued at up to $40,957.11, is a Delivery Order with a Firm Fixed Price pricing type. The award does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office Division, will supply the DLA with products such as the drug CellCept...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of mycophenolate 500 mg tablets. The contract has a ceiling value of $1,832.60 and a period of performance through August 5, 2024. The contract is a delivery order and utilizes a firm fixed-price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA72F
    Delivery Order

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,984.72 firm fixed-price contract is for the supply of CELLCEPT 500 MG TABLET 100S to support military healthcare programs. The contract has an ultimate completion date of January 7, 2025.

The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

There is no set-aside designation for this particular award. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 4/7/25, 10:48 AM